TECHNE CORP /MN/
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: TECHNE CORP /MN/, 10-Q, EX-3.1, 2000-11-14
Next: LEAR CORP /DE/, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-END>                               SEP-30-2000
<CASH>                                      21,257,529
<SECURITIES>                                49,494,945
<RECEIVABLES>                               15,704,123
<ALLOWANCES>                                   159,000
<INVENTORY>                                  4,538,498
<CURRENT-ASSETS>                            93,929,107
<PP&E>                                      63,710,805
<DEPRECIATION>                              17,230,578
<TOTAL-ASSETS>                             186,233,363
<CURRENT-LIABILITIES>                       11,883,107
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       207,257
<OTHER-SE>                                 148,613,605
<TOTAL-LIABILITY-AND-EQUITY>               186,233,363
<SALES>                                     27,721,563
<TOTAL-REVENUES>                            27,721,563
<CGS>                                        6,804,189
<TOTAL-COSTS>                                6,804,189
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             353,625
<INCOME-PRETAX>                             11,283,050
<INCOME-TAX>                                 3,780,000
<INCOME-CONTINUING>                          7,503,050
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 7,503,050
<EPS-BASIC>                                        .36
<EPS-DILUTED>                                      .35


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission